Physician profile
Omar A Ali
NPI 1881634848
$2,171.28
in general payments reported to CMS, 2019-2025
24 companies · $439 in 2025
The $439 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $87.36 · 2021: $125 · 2022: $337 · 2023: $239 · 2024: $437 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $426.64 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $296.76 | 2019-2025 | Wainua, Farxiga |
| Janssen Pharmaceuticals, INC | $209.70 | 2019-2024 | Xarelto |
| Pfizer INC. | $189.35 | 2019-2024 | |
| Boston Scientific Corporation | $133.13 | 2023-2025 | Opticross 6, Avvigo Guidance System, Wolverine Coronary Cutting Balloon |
| E.R. Squibb & Sons, L.L.C. | $100.71 | 2019-2023 | Camzyos |
| Amgen INC. | $97.17 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $92.67 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $83.44 | 2022-2023 | Verquvo |
| Medtronic Vascular, INC. | $80.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.89 | 2019 | |
| Medtronic, INC. | $57.52 | 2022 | |
| Abiomed | $54.51 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $39.48 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.25 | 2023-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $31.75 | 2025 | Indigo System |
| Cardiva Medical, INC. | $28.38 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Bard Peripheral Vascular, INC. | $24.77 | 2025 | Rotarexs 6 F X 135 Cm |
| Philips North America LLC | $21.17 | 2022 | |
| Lantheus Medical Imaging, INC. | $20.04 | 2022 | |
| Astellas Pharma US INC | $20.03 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.13 | 2025 | Amvuttra |
| Abbvie INC. | $14.96 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.